11/20/2007

Schering-Plough Corp. has concluded its $14.43 billion acquisition of Organon BioSciences NV, a Dutch biopharmaceutical company, in a deal that covers Organon's fertility treatment Follistim, muscle relaxant Zemuron, an asthma treatment and an HIV drug.

Related Summaries